Fang, F., Song, T., Wu, Q., Cui, Y., Zhang, W. (2026). Sintilimab combined with lenvatinib versus hepatic artery infusion chemotherapy (HAIC) for neoadjuvant treatment of resectable hepatocellular carcinoma with high risk of recurrence: A prospective, two-arm, randomized, phase II clinical study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.2_suppl.564